Theodore Levin to California
This is a "connection" page, showing publications Theodore Levin has written about California.
Connection Strength
1.217
-
Association between Improved Colorectal Screening and Racial Disparities. N Engl J Med. 2022 02 24; 386(8):796-798.
Score: 0.131
-
Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program. Gastroenterology. 2020 11; 159(5):1695-1704.e1.
Score: 0.117
-
Diagnosis and predictors of sessile serrated adenoma after educational training in a large, community-based, integrated healthcare setting. Gastrointest Endosc. 2018 Mar; 87(3):755-765.e1.
Score: 0.096
-
Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature. J Am Board Fam Med. 2016 11 12; 29(6):672-681.
Score: 0.091
-
Beyond Colonoscopy: The Role of Alternative Screening Tests for Colorectal Cancer in Your Practice. Am J Gastroenterol. 2017 01; 112(1):8-10.
Score: 0.090
-
Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer. Clin Gastroenterol Hepatol. 2013 Sep; 11(9):1158-66.
Score: 0.070
-
Diagnosis, comorbidities, and management of irritable bowel syndrome in patients in a large health maintenance organization. Clin Gastroenterol Hepatol. 2012 Jan; 10(1):37-45.
Score: 0.063
-
Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011; 33:101-10.
Score: 0.062
-
Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med. 2006 Dec 19; 145(12):880-6.
Score: 0.046
-
Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease. JAMA Netw Open. 2024 Jul 01; 7(7):e2421019.
Score: 0.038
-
Factors associated with colorectal cancer screening in a population-based study: the impact of gender, health care source, and time. Prev Med. 2004 Mar; 38(3):276-83.
Score: 0.038
-
Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. Gastroenterology. 2020 03; 158(4):884-894.e5.
Score: 0.028
-
Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death. Gastroenterology. 2019 01; 156(1):63-74.e6.
Score: 0.026
-
Costs of acid-related disorders to a health maintenance organization. Am J Med. 1997 Dec; 103(6):520-8.
Score: 0.024
-
Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program. Am J Prev Med. 2017 Sep; 53(3):335-344.
Score: 0.023
-
Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut. 2007 Jun; 56(6):756-62.
Score: 0.023
-
Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut. 2018 02; 67(2):291-298.
Score: 0.023
-
Ten-year incidence of colorectal cancer following a negative screening sigmoidoscopy: an update from the Colorectal Cancer Prevention (CoCaP) programme. Gut. 2016 Feb; 65(2):271-7.
Score: 0.020
-
Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting. Clin Gastroenterol Hepatol. 2015 Apr; 13(4):739-46.
Score: 0.020
-
Effectiveness and reach of the FLU-FIT program in an integrated health care system: a multisite randomized trial. Am J Public Health. 2013 Jun; 103(6):1128-33.
Score: 0.018
-
Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology. 2013 Mar; 57(3):881-9.
Score: 0.017
-
Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol. 2013 Feb; 11(2):172-80.
Score: 0.017
-
Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012 Aug; 143(2):382-9.
Score: 0.017
-
Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus. Gastroenterology. 2009 Mar; 136(3):806-15.
Score: 0.013
-
Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut. 2009 Feb; 58(2):182-8.
Score: 0.013
-
Cigarette smoking and the risk of Barrett's esophagus. Cancer Causes Control. 2009 Apr; 20(3):303-11.
Score: 0.013
-
Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus. Gastroenterology. 2008 Dec; 135(6):1914-23, 1923.e1.
Score: 0.013
-
Dietary patterns and the risk of Barrett's esophagus. Am J Epidemiol. 2008 Apr 01; 167(7):839-46.
Score: 0.012
-
Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007 Jul; 133(1):34-41; quiz 311.
Score: 0.012
-
PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States). Cancer Causes Control. 2006 Apr; 17(3):239-49.
Score: 0.011
-
CYP1A1, cigarette smoking, and colon and rectal cancer. Am J Epidemiol. 2004 Nov 01; 160(9):842-52.
Score: 0.010
-
Family history and colorectal cancer: predictors of risk. Cancer Causes Control. 2003 Nov; 14(9):879-87.
Score: 0.009
-
Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia. Am J Gastroenterol. 2001 Feb; 96(2):338-47.
Score: 0.008
-
Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol. 2000 Mar; 95(3):788-92.
Score: 0.007